CEACAM5 and neoplasm: It has been proposed that numerous tumour-specific surface antigens, including integrin αvβ6, CEA [64], EGFR, and urokinase plasminogen activator receptor (uPAR), have the potential to be employed primarily for detecting PDAC [89].